Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
16.36
-0.49 (-2.91%)
At close: Aug 29, 2025, 4:00 PM
16.37
+0.01 (0.06%)
After-hours: Aug 29, 2025, 7:58 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.61 billion as of August 29, 2025. Its market cap has decreased by -12.94% in one year.
Market Cap
1.61B
Enterprise Value
612.27M
1-Year Change
-12.94%
Ranking
Category
Stock Price
$16.36
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $1.61B, an increase of 390.23%. That is a compound annual growth rate of 33.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 1.61B | -18.55% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |